Inflammatory Cytokines and Chemokines in the Cerebrospinal Fluid of Multiple Sclerosis Patients Following Administration of Natalizumab

被引：0
|
作者：
Kithcart, Aaron P.
Lovett-Racke, Amy
Stueve, Olaf
Monsoon, Nancy
Whitacre, Caroline
Racke, Michael
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A555 / A555
页数：1
相关论文
共 50 条
  • [1] Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid
    Mellergard, J.
    Edstrom, M.
    Vrethem, M.
    Ernerudh, J.
    Dahle, C.
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (02) : 208 - 217
  • [2] Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis
    Callegari, Ilaria
    Schneider, Mika
    Aebischer, Vera
    Voortman, Margarete M. M.
    Proschmann, Undine
    Ziemssen, Tjalf
    Lindberg, Raija
    Fischer-Barnicol, Bettina
    Khalil, Michael
    Kappos, Ludwig
    Kuhle, Jens
    Sanderson, Nicholas S. R.
    Derfuss, Tobias
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2023, 16
  • [3] Effects of Natalizumab Treatment on the Cerebrospinal Fluid Proteome of Multiple Sclerosis Patients
    Stoop, Marcel P.
    Singh, Vaibhav
    Stingl, Christoph
    Martin, Roland
    Khademi, Mohsen
    Olsson, Tomas
    Hintzen, Rogier Q.
    Luider, Theo M.
    JOURNAL OF PROTEOME RESEARCH, 2013, 12 (03) : 1101 - 1107
  • [4] Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis
    Matejcikova, Z.
    Mares, J.
    Prikrylova-Vranova, H.
    Klosova, J.
    Sladkova, V.
    Zapletalova, J.
    Hlustik, P.
    Kanovsky, P.
    JOURNAL OF NEUROLOGY, 2014, 261 : S333 - S333
  • [5] Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis
    Matejcikova, Z.
    Mares, J.
    Prikrylova-Vranova, H.
    Klosova, J.
    Sladkova, V.
    Zapletalova, J.
    Hlustik, P.
    Kanovsky, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 505 - 505
  • [6] Multiparameter assay evaluation and quantification of inflammatory cytokines in cerebrospinal fluid and serum of multiple sclerosis patients
    Malekzadeh, A.
    Wijnstok, N.
    Twaalfhoven, H.
    van Oosten, B.
    de Groot, V.
    Blankenstein, M.
    Teunissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 270 - 271
  • [7] Multiplex array analysis of circulating cytokines and chemokines in natalizumab-treated patients with multiple sclerosis
    Villani, Sonia
    Zanotta, Nunzia
    Ambrogi, Federico
    Comar, Manola
    Franciotta, Diego
    Dolci, Maria
    Cason, Carolina
    Ticozzi, Rosalia
    Ferrante, Pasquale
    Delbue, Serena
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 310 : 91 - 96
  • [8] The Impact of Natalizumab Treatment on Cerebrospinal Fluid Oligoclonal Bands in Multiple Sclerosis Patients
    Jacques, Francois
    Metiegam, Ariane
    Timite, Halilou
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 306 - 306
  • [9] Correlation between Oxidatives Stress and Chemokines in the Cerebrospinal Fluid of Multiple Sclerosis Patients
    Ray, Hetal
    Lee, Donald
    Mir, Fozia
    Sadiq, Saud
    NEUROLOGY, 2013, 80
  • [10] Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients
    Khaibullin, Timur
    Ivanova, Vilena
    Martynova, Ekaterina
    Cherepnev, Georgy
    Khabirov, Farit
    Granatov, Evgenii
    Rizvanov, Albert
    Khaiboullina, Svetlana
    FRONTIERS IN IMMUNOLOGY, 2017, 8
12345